Hydralazine Hydrochloride Injection
Product Images NDC 68475-514

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 68475-514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (99678e1f Ed3c 48a8 8902 33f407eb0d8c 01)

Chemical structure of Hydralazine Hydrochloride, showing its compound arrangement including a phenyl group attached to a hydrazine functional group, and associated with hydrochloride (HCl).*

FDA Label Image

Vial (99678e1f Ed3c 48a8 8902 33f407eb0d8c 02)

Label for Hydralazine Hydrochloride Injection USP 20 mg/mL, a 1 mL single-dose vial for intramuscular or intravenous use. The preservative-free product is manufactured for Navinta LLC. The label includes storage instructions, a barcode, and manufacturing location details.*

FDA Label Image

Carton (99678e1f Ed3c 48a8 8902 33f407eb0d8c 03)

Packaging label for Hydralazine Hydrochloride Injection, USP 20 mg/mL by Navinta LLC. It is a human prescription drug available as a single-dose vial for intramuscular or intravenous use. The carton contains 25 vials, each 1 mL, preservative-free. Storage and usage instructions along with inactive ingredients and manufacturer details are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.